Kurs & Likviditet
Kalender
2023-10-31 | Kvartalsrapport 2023-Q3 |
2023-07-21 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Kvartalsrapport 2023-Q1 |
2023-03-22 | Ordinarie utdelning OKDBV 0.06 EUR |
2023-03-22 | Ordinarie utdelning OKDAV 0.06 EUR |
2023-03-21 | Årsstämma 2023 |
2023-02-16 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-07-22 | Kvartalsrapport 2022-Q2 |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-03-16 | Ordinarie utdelning OKDAV 0.04 EUR |
2022-03-16 | Ordinarie utdelning OKDBV 0.04 EUR |
2022-03-15 | Årsstämma 2022 |
2022-02-18 | Bokslutskommuniké 2021 |
2021-10-27 | Kvartalsrapport 2021-Q3 |
2021-07-20 | Kvartalsrapport 2021-Q2 |
2021-04-27 | Kvartalsrapport 2021-Q1 |
2021-03-17 | Ordinarie utdelning OKDAV 0.03 EUR |
2021-03-17 | Ordinarie utdelning OKDBV 0.03 EUR |
2021-03-16 | Årsstämma 2021 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-10-23 | Kvartalsrapport 2020-Q3 |
2020-07-17 | Kvartalsrapport 2020-Q2 |
2020-04-24 | Kvartalsrapport 2020-Q1 |
2020-03-18 | Ordinarie utdelning OKDBV 0.09 EUR |
2020-03-18 | Ordinarie utdelning OKDAV 0.09 EUR |
2020-03-17 | Årsstämma 2020 |
2020-02-07 | Bokslutskommuniké 2019 |
2019-07-17 | Kvartalsrapport 2019-Q2 |
2019-03-20 | Ordinarie utdelning OKDBV 0.09 EUR |
2019-03-20 | Ordinarie utdelning OKDAV 0.09 EUR |
2019-03-19 | Årsstämma 2019 |
2018-11-01 | Kvartalsrapport 2018-Q3 |
2018-07-18 | Kvartalsrapport 2018-Q2 |
2018-04-27 | Kvartalsrapport 2018-Q1 |
2018-03-20 | Ordinarie utdelning OKDAV 0.09 EUR |
2018-03-20 | Ordinarie utdelning OKDBV 0.09 EUR |
2018-03-19 | Årsstämma 2018 |
2018-02-13 | Bokslutskommuniké 2017 |
2017-10-25 | Kvartalsrapport 2017-Q3 |
2017-07-21 | Kvartalsrapport 2017-Q2 |
2017-04-28 | Kvartalsrapport 2017-Q1 |
2017-03-15 | Ordinarie utdelning OKDAV 0.14 EUR |
2017-03-15 | Ordinarie utdelning OKDBV 0.14 EUR |
2017-03-14 | Årsstämma 2017 |
2017-02-13 | Bokslutskommuniké 2016 |
2016-10-20 | Kvartalsrapport 2016-Q3 |
2016-07-19 | Kvartalsrapport 2016-Q2 |
2016-04-22 | Kvartalsrapport 2016-Q1 |
2016-03-15 | Ordinarie utdelning OKDAV 0.13 EUR |
2016-03-15 | Ordinarie utdelning OKDBV 0.13 EUR |
2016-03-14 | Årsstämma 2016 |
2016-02-05 | Bokslutskommuniké 2015 |
2015-10-22 | Kvartalsrapport 2015-Q3 |
2015-09-09 | Kapitalmarknadsdag 2015 |
2015-07-17 | Kvartalsrapport 2015-Q2 |
2015-04-23 | Kvartalsrapport 2015-Q1 |
2015-03-31 | Ordinarie utdelning OKDAV 0.00 EUR |
2015-03-31 | Ordinarie utdelning OKDBV 0.00 EUR |
2015-03-30 | Årsstämma 2015 |
2015-02-06 | Bokslutskommuniké 2014 |
2014-10-23 | Kvartalsrapport 2014-Q3 |
2014-07-24 | Kvartalsrapport 2014-Q2 |
2014-04-24 | Kvartalsrapport 2014-Q1 |
2014-03-25 | Ordinarie utdelning OKDAV 0.00 EUR |
2014-03-25 | Ordinarie utdelning OKDBV 0.00 EUR |
2014-03-24 | Årsstämma 2014 |
2014-02-07 | Bokslutskommuniké 2013 |
2013-10-24 | Kvartalsrapport 2013-Q3 |
2013-07-25 | Kvartalsrapport 2013-Q2 |
2013-04-25 | Kvartalsrapport 2013-Q1 |
2013-03-21 | Ordinarie utdelning OKDBV 0.09 EUR |
2013-03-21 | Ordinarie utdelning OKDAV 0.09 EUR |
2013-03-20 | Årsstämma 2013 |
2013-02-07 | Bokslutskommuniké 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-07-26 | Kvartalsrapport 2012-Q2 |
2012-04-26 | Kvartalsrapport 2012-Q1 |
2012-03-27 | Ordinarie utdelning OKDBV 0.08 EUR |
2012-03-27 | Ordinarie utdelning OKDAV 0.08 EUR |
2012-03-26 | Årsstämma 2012 |
2012-02-09 | Bokslutskommuniké 2011 |
2011-10-27 | Kvartalsrapport 2011-Q3 |
2011-08-04 | Kvartalsrapport 2011-Q2 |
2011-04-07 | Ordinarie utdelning |
2011-04-07 | Ordinarie utdelning |
2011-04-07 | Bonusutdelning |
2011-04-07 | Bonusutdelning |
2010-04-08 | Ordinarie utdelning |
2010-04-08 | Ordinarie utdelning |
2009-04-17 | Ordinarie utdelning |
2009-04-17 | Ordinarie utdelning |
2008-03-18 | Ordinarie utdelning |
2008-03-18 | Ordinarie utdelning |
2007-03-14 | Ordinarie utdelning |
2007-03-14 | Ordinarie utdelning |
Beskrivning
Land | Finland |
---|---|
Lista | Mid Cap Helsinki |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Oriola Corporation Insider Information 30 January 2023 at 9:10 a.m.
Oriola Corporation records EUR 9.8 million write-downs of other tangible and intangible assets and provides preliminary information on its year 2022 financial performance
Oriola Corporation records EUR 9.8 million write-downs of other tangible and intangible assets not yet available for use and which have been development in progress. The non-recurring write-downs do not have a cash flow effect. The write-downs are related to several earlier years process automation development, outdated information technology and partially implemented projects that have been discontinued. The write-downs are handled as adjusting items in Oriolas reporting.
Based on preliminary, unaudited information on the continuing operations, Oriola estimates that its net sales in 2022 was approximately EUR 1,515 million and adjusted EBIT was approximately EUR 19.7 million. The adjusted EBIT of Oriola's continued operations excludes the loss of EUR 0.8 million from the joint venture Swedish Pharmacy Holding AB in the fourth quarter in 2022.
The outlook for 2022 (published on 3 October 2022)
The adjusted EBIT for the continuing operations is estimated to increase from the 2021 level. The new outlook is based on Oriola's continuing operations.
The COVID-19 pandemic continues and the severity as well as the duration of the pandemic remain unclear in Oriola's operating environment. Furthermore, the recent overall inflationary increases and related cost pressures may have a significant impact on Oriola's profitability.
The comparable adjusted EBIT in 2021 was EUR 14.9 million for the continuing operations.
Oriola Corporation will publish its financial statements for 2022 on February 16, 2023.
Oriola Corporation
Timo Leinonen
CFO
Further information:
investor.relations@oriola.com
Mikael Wegmüller
VP, Communications and Sustainability
Tel. +358 40 776 2314
Email: mikael.wegmuller@oriola.com
Distribution:
Nasdaq Helsinki Ltd
Key media
Released by:
Oriola Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola.com